SCHEMBL13846232

SCHEMBL13846232

C=C(N)c1ccc(C)c([N+](=O)[O-])c1

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.65
CES2 O00748 1/20 0.58
CES1 P23141 1/20 0.58
ALDH1A1 P00352 7/20 0.56
CYP3A4 P08684 1/20 0.56
RECQL P46063 1/20 0.56
KMT2A Q03164 4/20 0.54
SMN1; SMN2 Q16637 3/20 0.54
MEN1 O00255 3/20 0.54
NPC1 O15118 3/20 0.54
RAB9A P51151 3/20 0.54
MAPT P10636 3/20 0.51
LMNA P02545 1/20 0.51
ATM Q13315 1/20 0.51
MAPK1 P28482 1/20 0.50
GAA P10253 1/20 0.50
POLB P06746 1/20 0.50
CTDSP1 Q9GZU7 1/20 0.50
HSP90AA1 P07900 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30686023 0.84 TSHR (0.72) TSHRCES2CES1ALDH1A1CYP3A4
SCHEMBL1086346 0.84 TSHR (0.72) TSHRCES2CES1ALDH1A1CYP3A4
SCHEMBL30955224 0.83 TSHR (0.65) TSHRCES2CES1ALDH1A1CYP3A4
Hydrochloric Acid SCHEMBL9202510 0.81 TSHR (0.63) TSHRCES2CES1ALDH1A1CYP3A4
SCHEMBL16959576 0.80 TSHR (0.71) TSHRCES2CES1ALDH1A1CYP3A4
SCHEMBL17303445 0.80 TSHR (0.77) TSHRCES2CES1ALDH1A1CYP3A4
SCHEMBL14738946 0.80 TSHR (0.61) TSHRCES2CES1ALDH1A1CYP3A4
SCHEMBL13495909 0.80 TSHR (0.61) TSHRCES2CES1ALDH1A1CYP3A4
SCHEMBL31261532 0.80 TSHR (0.61) TSHRCES2CES1ALDH1A1CYP3A4
SCHEMBL8280961 0.79 VCAM1 (0.67) ALDH1A1KMT2AMEN1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009064738-A2 TREATMENT OF BREAST CANCER WITH A PARP INHIBITOR ALONE OR IN COMBINATION WITH ANTI-TUMOR AGENTS BIPAR SCIENCES, INC. (US) 2009-05-22 WO disclosed